Shane Krauss, Author at Strados Labs

Unpacking the FDA Advisory Committee Meeting for Merck’s Gefapixant

by Shane Krauss | Mar 19, 2024 | Blog, Blog - Clinical Trial Focus

In November 2023, Merck’s chronic cough drug, gefapixant, faced a decisive setback from the FDA Advisory Committee. The concerns highlighted insufficient evidence for the drug providing a clinically meaningful benefit to adults with refractory chronic cough...

Introducing New Grant Initiative to Accelerate Research into Lung Sound Monitoring

Unpacking the FDA Advisory Committee Meeting for Merck’s Gefapixant

Recent Posts

Sitemap

Follow Us

Get In Touch

Success!